BioNexus Gene Lab Corp

BGLC - CIK 0001737523

Market cap-

Rank-

SEC filings140

BGLC balance sheet (annual)

The table below shows BioNexus Gene Lab Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$2.49M	-	-	-	$2.12M	$2.79M
Short-term investments	-	-	-	-	-	-
Receivables	$505.88K	-	-	-	-	-
Inventory	$676.70K	$1.39M	$1.14M	$977.81K	$1.52M	$1.18M
Total current assets

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.